Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.
Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321. J Clin Oncol. 2006 Feb 20; 24(6):929-36.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Bone Marrow Transplantation
Carmustine
Chemotherapy, Adjuvant
Clinical Protocols
Cyclophosphamide
Disease-Free Survival
Drug Administration Schedule
Female
Hematopoietic Stem Cell Transplantation
Humans
Interferons
Male
Melphalan
Middle Aged
Multiple Myeloma
Prednisone
Prospective Studies
Radiotherapy, Adjuvant
Salvage Therapy
Survival Analysis
Transplantation, Autologous
Transplantation, Homologous
Treatment Failure
Treatment Outcome
United States
Vincristine
Whole-Body Irradiation
authors with profiles
Kenneth Carl Anderson, M.D.